Abstract
We retrospectively compared the clinicopathological features of primary intestinal follicular lymphomas (FL-GIs), nodal follicular lymphomas (FL-LNs) and gastrointestinal MALT lymphomas (MALT-GIs), and investigated the distribution and the endoscopic appearances of FL-GI to evaluate the effectiveness of treatment modality. The subjects were 28 FL-GI patients, 135 FL-LN patients and 70 MALT-GI patients. In FL-LNs the clinical stage III–IV was 83%, while in FL-GIs clinical stage I–II was 68%. In MALT-GIs clinical stage I–II was 87%. The overall survival was significantly better in MALT-GI patients than in FL-LN patients. All FL-GI patients were alive at the time of evaluation. Regarding the histological grade (WHO), grade 1 was 81% in FL-GI, whereas in FL-LN grade 2 was 28% and grade 3 was 11%. The Follicular Lymphoma International Prognostic Index was low in 61% of FL-GIs, while in FL-LNs it was equally distributed to low, intermediate and high, suggesting that the prognosis is better in FL-GIs than in FL-LNs. The clinicopathological studies revealed the FL-GI has intermediate characteristics between FL-LN and MALT-GI. We recommend a ‘watch-and-wait’ policy or chemotherapy with rituximab for the therapy of FL-GIs because the lesions are often located in broader areas from the lower duodenum to the small intestine.
References
1.
Aisenberg AC: Coherent view of non-Hodgkin’s lymphoma. J Clin Oncol 1995;13:2656–2675.
[PubMed]
2.
Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, Au WY, Bellei M, Brice P, Caballero D, Coiffier B, Conde-Garcia E, Doyen C, Federico M, Fisher RI, Garcia-Conde JF, Guglielmi C, Hagenbeek A, Haïoun C, LeBlanc M, Lister AT, Lopez-Guillermo A, McLaughlin P, Milpied N, Morel P, Mounier N, Proctor SJ, Rohatiner A, Smith P, Soubeyran P, Tilly H, Vitolo U, Zinzani PL, Zucca E, Montserrat E: Follicular lymphoma international prognostic index. Blood 2004;104:1258–1265.
[PubMed]
3.
Federico M, Vitolo U, Zinzani PL, Chisesi T, Clò V, Bellesi G, Magagnoli M, Liberati M, Boccomini C, Niscola P, Pavone V, Cuneo A, Santini G, Brugiatelli M, Baldini L, Rigacci L, Resegotti L, for the Intergruppo Italiano Linfomi: Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 2000;95:783–789.
[PubMed]
4.
The Non-Hodgkin’s Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 1997;89:3909–3918.
[PubMed]
5.
Glick JH, Barnes JM, Ezdinli EZ, Berard CW, Orlow EL, John M, Bennett JM: Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 1981;58:920–925.
[PubMed]
6.
Dana BW, Dahlberg S, Nathwani BN, Chase E, Coltman C, Miller TP, Fisher RI: Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 1993;11:644–651.
[PubMed]
7.
Tanaka S, Onoue G, Fujimoto T, Kosaka T, Yamasaki H, Yasui Y, Konaga E, Teramoto N, Okada H, Mizuno M, Shiratori Y: A case of primary follicular lymphoma in the duodenum confined to the mucosal layer. J Clin Gastroenterol 2002;35:285–286.
[PubMed]
8.
Shia J, Teruya-Feldstein J, Pan D, Hegde A, Klimstra DS, Chaganti RSK, Qin J, Portlock CS, Filippa DA: Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol 2002;26:216–224.
[PubMed]
9.
Nadal E, Martinez A, Jimenez M, et al: Primary follicular lymphoma arising in the ampulla of Vater. Ann Hematol 2002;81:228–231.
[PubMed]
10.
Nomura K, Sekoguchi S, Ueda K, Nakao M, Akano Y, Fujita Y, Yamashita Y, Horiike S, Nishida K, Nakamura S, Taniwaki M: Differentiation of follicular from mucosa-associated lymphoid tissue lymphoma by detection of t(14;18) on single-cell preparations and paraffin-embedded sections. Genes Chromosomes Cancer 2002;33:213–216.
[PubMed]
11.
Bende RJ, Smit LA, Bossenbroek JG, Aarts WM, Spaargaren M, de Leval L, Boeckxstaens GEE, Pals ST, van Noesel CJM: Primary follicular lymphoma of the small intestine: α4β7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003;162:105–113.
[PubMed]
12.
Matsuzawa M, Shimodaira K, Nakamura N, Ochi Y, Hosaka S, Kiyosawa K, Matsuzawa M, Akamatsu T, Sugiyama A, Ota H, Katsuyama T: A case of primary follicular lymphoma of the duodenum with BCL-2 gene rearrangement. J Gastroenterol 2003;38:512–513.
[PubMed]
13.
Goodlad JR, MacPherson S, Jackson R, et al: Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non-cutaneous extranodal sites. Histopathology 2004;44:268–276.
[PubMed]
14.
Tang Z, Jing W, Lindeman N, et al: One patient, two lymphomas. Simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma. Arch Pathol Lab Med 2004;128:1035–1038.
[PubMed]
15.
Toyoda H, Yamaguchi M, Nakamura S, Nakamura T, Kimura M, Suzuki H, Mukai K, Sawa H, Kawamura K, Hiroshi Shiku H: Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. Gastrointest Endosc 2001;54:92–96.
[PubMed]
16.
Sato Y, Ichimura K, Tanaka T, Takata K, Morito T, Sato H, Kondo E, Yanai H, Ohara N, Oka T, Yoshino T: Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas. J Clin Pathol 2008;61:377–381.
[PubMed]
17.
Yamamoto H, Kita H, Sunada K, Hayashi Y, Sato H, Yano T, Iwamoto M, Sekine Y, Miyata T, Kuno A, Ajibe H, Ido K, Sugano K: Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small intestinal diseases. Clin Gastroenterol Hepatol 2004;2:1010–1016.
[PubMed]
18.
Kodama M, Kitadai Y, Shishido T, Shimamoto M, Fukumoto A, Masuda H, Tanaka S, Yoshihara M, Sakai A, Nakayama H, Chayama K: Primary follicular lymphoma of the gastrointestinal tract: a retrospective case series. Endoscopy 2008;40:343–346.
[PubMed]
19.
Carbone PP, Kaplan HS, Musshoff K, David W, Smithers DW, Maurice Tubiana M: Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 1971;31:1860–1861.
[PubMed]
20.
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–655.
[PubMed]
21.
Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classifications of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2008.
22.
Taniwaki M, Ueda Y, Nishida K, Takashima T, Kashima K, Matsuda F, Silverman GA: Rapid detection of lymphoma-specific translocations in interphase nuclei of non-Hodgkin’s lymphoma by fluorescence in situ hybridization. Leukemia 1997;11(suppl 3):291– 293.
[PubMed]
23.
Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M: A novel gene, MALT1 at 18q21, is involved in t(11;18)(q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999;18:5785–5794.
[PubMed]
24.
Liu YX, Yoshino T, Ohara N, et al: Loss of expression of α4β7 integrin and L-selectin is associated with high-grade progression of low-grade MALT lymphoma. Mod Pathol 2001;14:798–805.
[PubMed]
25.
Takata K, Sato Y, Nakamura N, et al: Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol 2009;22:940–949.
[PubMed]
26.
Tari A, Sato Y, Asaoku H, Kunihiro M, Fukumoto A, Tanaka S, Fujihara M, Yoshino T: A duodenal follicular lymphoma associated with the lesion mimicking MALT lymphoma in terminal ileum and Bauhin’s valve. Med Mol Morphol 2010;43:174–177.
[PubMed]
© 2011 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2011
You do not currently have access to this content.
